Common Stock, Shares, Outstanding of ALPINE IMMUNE SCIENCES, INC. from 31 Dec 2014 to 31 Mar 2024

Taxonomy & unit
us-gaap: shares
Description
Number of shares of common stock outstanding. Common stock represent the ownership interest in a corporation.
Summary
ALPINE IMMUNE SCIENCES, INC. quarterly Common Stock, Shares, Outstanding in shares history and change rate from 31 Dec 2014 to 31 Mar 2024.
  • ALPINE IMMUNE SCIENCES, INC. Common Stock, Shares, Outstanding for the quarter ending 31 Mar 2024 was 65,552,322, a 37% increase year-over-year.
Source SEC data
View on sec.gov
Common Stock, Shares, Outstanding, Quarterly (shares)
Common Stock, Shares, Outstanding, YoY Quarterly Change (%)

ALPINE IMMUNE SCIENCES, INC. Quarterly Common Stock, Shares, Outstanding (shares)

Period Value YoY Chg Change % Date Report Filed Fiscal Year Fiscal Period
Q1 2024 65,552,322 +17,794,315 +37% 31 Mar 2024 10-Q 09 May 2024 2024 Q1
Q4 2023 60,347,457 +14,363,024 +31% 31 Dec 2023 10-Q 09 May 2024 2024 Q1
Q3 2023 49,274,160 +5,263,009 +12% 30 Sep 2023 10-Q 14 Nov 2023 2023 Q3
Q2 2023 49,124,640 +18,788,478 +62% 30 Jun 2023 10-Q 14 Aug 2023 2023 Q2
Q1 2023 47,758,007 +17,463,573 +58% 31 Mar 2023 10-Q 11 May 2023 2023 Q1
Q4 2022 45,984,433 +15,790,154 +52% 31 Dec 2022 10-K 20 Mar 2024 2023 FY
Q3 2022 44,011,151 +14,793,459 +51% 30 Sep 2022 10-Q 14 Nov 2022 2022 Q3
Q2 2022 30,336,162 +6,421,283 +27% 30 Jun 2022 10-Q 11 Aug 2022 2022 Q2
Q1 2022 30,294,434 +6,412,296 +27% 31 Mar 2022 10-Q 12 May 2022 2022 Q1
Q4 2021 30,194,279 +6,391,096 +27% 31 Dec 2021 10-K 23 Mar 2023 2022 FY
Q3 2021 29,217,692 +5,414,509 +23% 30 Sep 2021 10-Q 10 Nov 2021 2021 Q3
Q2 2021 23,914,879 +5,323,648 +29% 30 Jun 2021 10-Q 10 Aug 2021 2021 Q2
Q1 2021 23,882,138 +5,294,246 +28% 31 Mar 2021 10-Q 13 May 2021 2021 Q1
Q4 2020 23,803,183 +5,215,291 +28% 31 Dec 2020 10-K 17 Mar 2022 2021 FY
Q3 2020 23,803,183 +5,215,415 +28% 30 Sep 2020 10-Q 12 Nov 2020 2020 Q3
Q2 2020 18,591,231 +6,501 +0.04% 30 Jun 2020 10-Q 11 Aug 2020 2020 Q2
Q1 2020 18,587,892 +26,863 +0.14% 31 Mar 2020 10-Q 14 May 2020 2020 Q1
Q4 2019 18,587,892 +4,733,687 +34% 31 Dec 2019 10-K 18 Mar 2021 2020 FY
Q3 2019 18,587,768 +4,735,304 +34% 30 Sep 2019 10-Q 14 Nov 2019 2019 Q3
Q2 2019 18,584,730 +4,733,968 +34% 30 Jun 2019 10-Q 13 Aug 2019 2019 Q2
Q1 2019 18,561,029 +4,714,945 +34% 31 Mar 2019 10-Q 09 May 2019 2019 Q1
Q4 2018 13,854,205 +23,027 +0.17% 31 Dec 2018 10-K 30 Mar 2020 2019 FY
Q3 2018 13,852,464 -29,181 -0.21% 30 Sep 2018 10-Q 08 Nov 2018 2018 Q3
Q2 2018 13,850,762 -1,805,489 -12% 30 Jun 2018 10-Q 09 Aug 2018 2018 Q2
Q1 2018 13,846,084 -1,810,167 -12% 31 Mar 2018 10-Q 14 May 2018 2018 Q1
Q4 2017 13,831,178 +13,222,477 +2172% 31 Dec 2017 10-K 18 Mar 2019 2018 FY
Q3 2017 13,881,645 -1,623,689 -10% 30 Sep 2017 10-Q 14 Nov 2017 2017 Q3
Q2 2017 15,656,251 +171,157 +1.1% 30 Jun 2017 10-Q 21 Jul 2017 2017 Q2
Q1 2017 15,656,251 +194,221 +1.3% 31 Mar 2017 10-Q 02 May 2017 2017 Q1
Q4 2016 608,701 -14,853,329 -96% 31 Dec 2016 10-K 28 Mar 2018 2017 FY
Q3 2016 15,505,334 +53,513 +0.35% 30 Sep 2016 10-Q 07 Nov 2016 2016 Q3
Q2 2016 15,485,094 +33,273 +0.22% 30 Jun 2016 10-Q 02 Aug 2016 2016 Q2
Q1 2016 15,462,030 31 Mar 2016 10-Q 03 May 2016 2016 Q1
Q4 2015 15,462,030 +13,250,872 +599% 31 Dec 2015 10-K 13 Feb 2017 2016 FY
Q3 2015 15,451,821 30 Sep 2015 10-Q 03 Nov 2015 2015 Q3
Q2 2015 15,451,821 30 Jun 2015 10-Q 04 Aug 2015 2015 Q2
Q4 2014 2,211,158 31 Dec 2014 10-K 08 Mar 2016 2015 FY
* An asterisk sign (*) next to the value indicates that the value is likely invalid.